# Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)

> **NCT00087516** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 741 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Sitagliptin (MK0431)
- **DRUG:** Sitagliptin
- **DRUG:** Placebo
- **DRUG:** Placebo
- **DRUG:** Metformin - Rescue

## Key facts

- **NCT ID:** NCT00087516
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2005-07
- **Final completion:** 2007-02
- **Target enrollment:** 741 (ACTUAL)
- **Last updated:** 2015-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00087516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00087516, "Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00087516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*